ABEO Financial Statements

Balance sheet, income statement, cash flow, and dividends for Abeona Therapeutics Inc (ABEO).


$242.13M Market Cap.

As of 03/20/2025 5:00 PM ET (MRY) • Disclaimer

ABEO Market Cap. (MRY)


ABEO Shares Outstanding (MRY)


ABEO Assets (MRY)


Total Assets

$108.93M

Total Liabilities

$64.90M

Total Investments

$74.36M

ABEO Income (MRY)


Revenue

$0

Net Income

-$63.73M

Operating Expense

$64.21M

ABEO Cash Flow (MRY)


CF Operations

-$56.02M

CF Investing

-$39.24M

CF Financing

$104.14M

ABEO Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ABEO Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$108,931,000 (70.20%)

$64,002,000 (-0.33%)

$64,214,000 (-19.31%)

$79,586,000 (-47.36%)

Assets Current

$100,853,000 (80.94%)

$55,737,000 (4.97%)

$53,099,000 (-5.67%)

$56,292,000 (-42.41%)

Assets Non-Current

$8,078,000 (-2.26%)

$8,265,000 (-25.64%)

$11,115,000 (-52.28%)

$23,294,000 (-56.42%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$1,384,000 (-95.93%)

Shareholders Equity

$44,031,000 (196.99%)

$14,826,000 (-44.60%)

$26,761,000 (-36.84%)

$42,368,000 (-58.69%)

Property Plant & Equipment Net

$7,982,000 (-0.08%)

$7,988,000 (-27.85%)

$11,072,000 (-49.08%)

$21,742,000 (18.46%)

Cash & Equivalents

$23,695,000 (59.98%)

$14,811,000 (1.76%)

$14,555,000 (-62.52%)

$38,829,000 (208.26%)

Accumulated Other Comprehensive Income

$8,000 (112.12%)

-$66,000 (48.84%)

-$129,000 (-377.78%)

-$27,000 (-170.00%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$74,363,000 (96.97%)

$37,753,000 (-0.47%)

$37,932,000 (213.85%)

$12,086,000 (-85.34%)

Investments Current

$74,363,000 (96.97%)

$37,753,000 (-0.47%)

$37,932,000 (213.85%)

$12,086,000 (-85.34%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$1,652,000 (-32.41%)

$2,444,000 (1200.00%)

$188,000 (-93.73%)

$3,000,000 (0%)

Trade & Non-Trade Payables

$3,441,000 (85.20%)

$1,858,000 (-68.90%)

$5,974,000 (-26.73%)

$8,153,000 (73.65%)

Accumulated Retained Earnings (Deficit)

-$813,258,000 (-8.50%)

-$749,524,000 (-7.79%)

-$695,336,000 (-6.05%)

-$655,640,000 (-14.88%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$23,048,000 (326.81%)

$5,400,000 (-29.20%)

$7,627,000 (-18.67%)

$9,378,000 (7.41%)

Debt Current

$6,749,000 (576.25%)

$998,000 (-43.71%)

$1,773,000 (-2.48%)

$1,818,000 (-11.01%)

Debt Non-Current

$16,299,000 (270.26%)

$4,402,000 (-24.80%)

$5,854,000 (-22.57%)

$7,560,000 (13.04%)

Total Liabilities

$64,900,000 (31.97%)

$49,176,000 (31.30%)

$37,453,000 (0.63%)

$37,218,000 (-23.49%)

Liabilities Current

$16,587,000 (23.58%)

$13,422,000 (72.54%)

$7,779,000 (-53.20%)

$16,623,000 (-60.38%)

Liabilities Non-Current

$48,313,000 (35.13%)

$35,754,000 (20.49%)

$29,674,000 (44.08%)

$20,595,000 (207.94%)

ABEO Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$3,500,000 (147.52%)

$1,414,000 (-52.87%)

$3,000,000 (-70.00%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$29,851,000 (57.08%)

$19,004,000 (10.13%)

$17,256,000 (-20.27%)

$21,644,000 (-8.98%)

Research & Development Expense

$34,360,000 (10.51%)

$31,091,000 (7.34%)

$28,965,000 (-25.21%)

$38,726,000 (28.49%)

Operating Expenses

$64,211,000 (30.96%)

$49,030,000 (-5.49%)

$51,879,000 (-44.12%)

$92,836,000 (1.55%)

Interest Expense

$4,208,000 (906.70%)

$418,000 (-43.21%)

$736,000 (-79.87%)

$3,656,000 (-11.15%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$63,734,000 (-17.62%)

-$54,188,000 (-36.51%)

-$39,696,000 (53.26%)

-$84,936,000 (-0.83%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$63,734,000 (-17.62%)

-$54,188,000 (-36.51%)

-$39,696,000 (53.26%)

-$84,936,000 (-0.83%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$3,782,000 (0%)

$0 (0%)

Net Income Common Stock

-$63,734,000 (-17.62%)

-$54,188,000 (-24.63%)

-$43,478,000 (48.81%)

-$84,936,000 (-0.83%)

Weighted Average Shares

$41,048,206 (91.99%)

$21,380,476 (171.96%)

$7,861,515 (99.65%)

$3,937,676 (6.24%)

Weighted Average Shares Diluted

$41,048,206 (91.99%)

$21,380,476 (171.96%)

$7,861,515 (99.65%)

$3,937,676 (6.24%)

Earning Before Interest & Taxes (EBIT)

-$59,526,000 (-10.70%)

-$53,770,000 (-38.01%)

-$38,960,000 (52.07%)

-$81,280,000 (-1.45%)

Gross Profit

$0 (0%)

$3,500,000 (147.52%)

$1,414,000 (-52.87%)

$3,000,000 (-70.00%)

Operating Income

-$64,211,000 (-41.03%)

-$45,530,000 (9.78%)

-$50,465,000 (43.83%)

-$89,836,000 (-10.34%)

ABEO Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$39,240,000 (-18965.38%)

$208,000 (100.87%)

-$23,964,000 (-136.28%)

$66,062,000 (178.91%)

Net Cash Flow from Financing

$104,139,000 (181.02%)

$37,057,000 (-14.17%)

$43,173,000 (73.66%)

$24,861,000 (1184.14%)

Net Cash Flow from Operations

-$56,015,000 (-51.36%)

-$37,009,000 (14.89%)

-$43,483,000 (33.78%)

-$65,665,000 (-87.51%)

Net Cash Flow / Change in Cash & Cash Equivalents

$8,884,000 (3370.31%)

$256,000 (101.05%)

-$24,274,000 (-196.10%)

$25,258,000 (121.63%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$36,812,000 (-11088.66%)

$335,000 (101.31%)

-$25,568,000 (-136.41%)

$70,213,000 (185.23%)

Capital Expenditure

-$2,428,000 (-1811.81%)

-$127,000 (-107.92%)

$1,604,000 (138.64%)

-$4,151,000 (-210.70%)

Issuance (Repayment) of Debt Securities

$19,037,000 (12791.33%)

-$150,000 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$85,102,000 (128.73%)

$37,207,000 (-20.76%)

$46,955,000 (88.87%)

$24,861,000 (13866.85%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$6,628,000 (39.01%)

$4,768,000 (56.28%)

$3,051,000 (-65.78%)

$8,916,000 (8.90%)

Depreciation Amortization & Accretion

$2,907,000 (-9.10%)

$3,198,000 (-30.13%)

$4,577,000 (2.53%)

$4,464,000 (-20.30%)

ABEO Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-

-1548.20% (49.65%)

-3074.80% (-8.60%)

-2831.20% (-236.13%)

EBITDA Margin

-

-1444.90% (40.58%)

-2431.60% (5.03%)

-2560.50% (-243.60%)

Return on Average Equity (ROAE)

-165.40% (50.43%)

-333.70% (-79.80%)

-185.60% (-64.25%)

-113.00% (-58.04%)

Return on Average Assets (ROAA)

-58.20% (36.39%)

-91.50% (-6.77%)

-85.70% (-18.70%)

-72.20% (-39.38%)

Return on Sales (ROS)

-

-1536.30% (44.24%)

-2755.30% (-1.70%)

-2709.30% (-238.16%)

Return on Invested Capital (ROIC)

-63.50% (43.56%)

-112.50% (8.91%)

-123.50% (43.04%)

-216.80% (-114.44%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-3.59 (-81.52%)

-1.98 (-255.48%)

-0.56 (-42.46%)

-0.39 (77.33%)

Price to Sales Ratio (P/S)

-

30.61 (78.73%)

17.12 (54.86%)

11.06 (-23.99%)

Price to Book Ratio (P/B)

5.5 (-34.31%)

8.37 (323.42%)

1.98 (143.77%)

0.81 (-46.22%)

Debt to Equity Ratio (D/E)

1.47 (-55.56%)

3.32 (136.93%)

1.4 (59.45%)

0.88 (85.23%)

Earnings Per Share (EPS)

-1.55 (38.74%)

-2.53 (54.25%)

-5.53 (74.36%)

-21.57 (5.19%)

Sales Per Share (SPS)

0 (0%)

0.16 (-8.89%)

0.18 (-76.38%)

0.76 (-71.76%)

Free Cash Flow Per Share (FCFPS)

-1.42 (18.02%)

-1.74 (67.39%)

-5.33 (69.95%)

-17.73 (-80.77%)

Book Value Per Share (BVPS)

1.07 (54.83%)

0.69 (-79.64%)

3.4 (-68.36%)

10.76 (-61.11%)

Tangible Assets Book Value Per Share (TABVPS)

2.65 (-11.33%)

2.99 (-63.36%)

8.17 (-58.87%)

19.86 (-37.21%)

Enterprise Value Over EBIT (EV/EBIT)

-4 (-100.00%)

-2 (-100.00%)

-1 (0%)

0 (0%)

Enterprise Value Over EBITDA (EV/EBITDA)

-4.4 (-78.39%)

-2.47 (-69.20%)

-1.46 (-3490.70%)

0.04 (102.06%)

Asset Turnover

0 (0%)

0.06 (110.71%)

0.03 (12.00%)

0.03 (-59.68%)

Current Ratio

6.08 (46.40%)

4.15 (-39.16%)

6.83 (101.59%)

3.39 (45.38%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$58,443,000 (-57.38%)

-$37,136,000 (11.33%)

-$41,879,000 (40.02%)

-$69,816,000 (-92.04%)

Enterprise Value (EV)

$249,178,637 (99.73%)

$124,756,318 (148.89%)

$50,124,461 (1633.02%)

-$3,269,663 (-102.11%)

Earnings Before Tax (EBT)

-$63,734,000 (-17.62%)

-$54,188,000 (-36.51%)

-$39,696,000 (53.26%)

-$84,936,000 (-0.83%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$56,619,000 (-11.96%)

-$50,572,000 (-47.08%)

-$34,383,000 (55.24%)

-$76,816,000 (-3.08%)

Invested Capital

$91,697,000 (122.73%)

$41,169,000 (-16.84%)

$49,507,000 (54.09%)

$32,128,000 (-55.01%)

Working Capital

$84,266,000 (99.14%)

$42,315,000 (-6.63%)

$45,320,000 (14.25%)

$39,669,000 (-28.89%)

Tangible Asset Value

$108,931,000 (70.20%)

$64,002,000 (-0.33%)

$64,214,000 (-17.89%)

$78,202,000 (-33.29%)

Market Capitalization

$242,133,637 (95.09%)

$124,114,318 (134.61%)

$52,901,461 (54.02%)

$34,346,337 (-77.80%)

Average Equity

$38,541,000 (137.36%)

$16,237,250 (-30.69%)

$23,425,750 (-68.83%)

$75,147,000 (-36.19%)

Average Assets

$109,588,500 (84.97%)

$59,246,000 (16.82%)

$50,716,500 (-56.90%)

$117,678,000 (-27.58%)

Invested Capital Average

$93,671,250 (95.93%)

$47,808,250 (51.59%)

$31,537,250 (-15.88%)

$37,489,750 (-52.68%)

Shares

43,471,030 (75.48%)

24,773,317 (44.23%)

17,175,799 (321.31%)

4,076,717 (3.44%)